Metabolic syndrome (MS) represents worldwide public health issue characterized by a set of
cardiovascular risk factors including obesity, diabetes, dyslipidemia, hypertension, and …

Metabolic syndrome is co-occurrence of obesity, insulin resistance, atherogenic
dyslipidemia (high triglyceride, low high density lipoprotein cholesterol), and hypertension. It …

Metabolic complications in an obese state can be aggravated by an abnormal inflammatory
response and enhanced production of reactive oxygen species. Pro-inflammatory response …

Diet plays a role in the onset and progression of metabolic disorders, including metabolic
syndrome (MetS). We aimed to systematically review and conduct a quantitative meta …

Metabolic syndrome (MetS) is defined as the co‐occurrence of metabolic risk factors that
includes insulin resistance, hyperinsulinemia, impaired glucose tolerance, type 2 diabetes …

The metabolic syndrome is a clustering condition of increased abdominal obesity in concert
with hyperglycemia, insulin resistance, hypertension, and dyslipidemia. It confers higher risk …

Capsaicin, the major active constituent of chilli, is an agonist on transient receptor potential
vanilloid channel 1 (TRPV1). TRPV1 is present on many metabolically active tissues …

γ-oryzanol (Orz), a steryl ferulate extracted from rice bran layer, exerts a wide spectrum of
biological activities. In addition to its antioxidant activity, Orz is often associated with …

Abstract Significance: Metabolic syndrome (MetS) is associated with a greater risk of
diabetes and cardiovascular diseases. It is estimated that this multifactorial condition affects …

The metabolic syndrome is a cluster of disorders dominated by abdominal obesity,
hypertriacylglycerolaemia, low HDL-cholesterol, high blood pressure and high fasting …